BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 6345669)

  • 1. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
    Miller SC
    J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras.
    Dupuy JM; Dupuy C; Décarie D
    J Immunol; 1984 Sep; 133(3):1609-13. PubMed ID: 6146650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
    Miller SC
    Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
    Kosmatopoulos K; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient natural defense mechanisms against Listeria monocytogenes in T and B cell-deficient allogeneic bone marrow radiation chimeras. Preactivated macrophages are the main effector cells in an early phase after bone marrow transfer.
    Roesler J; Gröttrup E; Baccarini M; Lohmann-Mattes ML
    J Immunol; 1989 Sep; 143(5):1710-5. PubMed ID: 2668412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation.
    Lapidot T; Singer TS; Salomon O; Terenzi A; Schwartz E; Reisner Y
    J Immunol; 1988 Oct; 141(8):2619-24. PubMed ID: 3049814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
    Slavin S; Seidel HJ
    Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two subpopulations of stem cells for T cell lineage.
    Katsura Y; Amagai T; Kina T; Sado T; Nishikawa S
    J Immunol; 1985 Nov; 135(5):3021-7. PubMed ID: 3900201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of cell mediating spontaneous resistance to bone marrow allografts.
    Miller SC; Poirier L
    Immunobiology; 1988 Dec; 178(3):191-202. PubMed ID: 2906627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
    Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
    Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrow.
    Nakamura H; Gress RE
    Transplantation; 1990 Feb; 49(2):453-8. PubMed ID: 2305471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.